Heilung & Regeneration 2 min read

TB-500

META-TITLE: [TODO: TB-500 — Thymosin Beta-4 Research Profile | Brand]
META-DESC: [TODO: TB-500 (Thymosin Beta-4) research overview — actin regulation, tissue repair mechanisms, dosing, safety.]

[TODO] Hook — TB-500 as a synthetic fragment of Thymosin Beta-4, widely studied for tissue repair and recovery, originally identified in thymus gland

[IMAGE: TB-500 molecular structure — 43 amino acid peptide visualization]

What is TB-500?

[TODO] Full name — TB-500, synthetic version of Thymosin Beta-4 (Tβ4)
[TODO] Origin — naturally occurring 43-amino acid peptide, found in all human/animal cells
[TODO] Key protein — primary G-actin sequestering peptide in mammalian cells
[TODO] Molecular weight — 4921 Da
[TODO] Systemic action — unlike BPC-157, travels systemically to injury sites via bloodstream

Mechanism of Action

[IMAGE: TB-500 mechanism diagram — actin polymerization, cell migration, angiogenesis pathways]

[TODO] Actin regulation — sequesters G-actin, promotes cell migration and cytoskeletal reorganization
[TODO] Angiogenesis — robust new blood vessel formation, VEGF-independent pathway
[TODO] Anti-inflammatory — downregulates inflammatory cytokines, NF-κB modulation
[TODO] Stem cell mobilization — promotes differentiation and migration to injury sites
[TODO] Anti-fibrotic — reduces scar formation, promotes functional tissue repair

Research Highlights

[TODO] Cardiac — post-MI cardiac repair, cardiomyocyte survival (mouse models)
[TODO] Dermal — accelerated wound closure, hair regrowth (animal models)
[TODO] Corneal — corneal wound healing, RegeneRx Phase 2 trials (RGN-259)
[TODO] Musculoskeletal — muscle fiber repair, reduced inflammation post-injury
[TODO] Neurological — CNS repair potential, remyelination studies

Dosing Protocols (Research Context)

[TODO] Loading phase — 4-8mg per week for first 4-6 weeks
[TODO] Maintenance — 2-4mg every 2 weeks
[TODO] Administration — subcutaneous or intramuscular, systemic distribution
[TODO] Storage — lyophilized, reconstitute with BAC water, refrigerate

Safety & Considerations

[TODO] Tolerability — well-tolerated in animal studies, minimal reported side effects
[TODO] Cancer concern — theoretical: angiogenesis promotion could feed existing tumors
[TODO] WADA — prohibited substance in competitive sports
[TODO] Human data — limited to Tβ4 eye drop trials (RGN-259), systemic human data lacking